SmartCentres Real Estate Investment Trust Releases Fourth 9-02-2023, 06:28

SAFEGUARD PROVIDES SUMMARY IMPACT ASSESSMENT FOLLOWING 13-03-2023, 22:20

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51